Phase III Randomized Intergroup Trial of Subtotal Lymphoid Irradiation Versus Doxorubicin, Vinblastine, and Subtotal Lymphoid Irradiation for Stage IA to IIA Hodgkin’s Disease
PRESS, Oliver W, LEBLANC, Michael, LICHTER, Allen S, GROGAN, Thomas M, UNGER, Joseph M, WASSERMAN, Todd H, GAYNOR, Ellen R, PETERSON, Bruce A, MILLER, Thomas P, FISHER, Richard I
Published in Journal of clinical oncology (15.11.2001)
Published in Journal of clinical oncology (15.11.2001)
Get full text
Journal Article
A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma
Weiss, G R, Margolin, K A, Aronson, F R, Sznol, M, Atkins, M B, Dutcher, J P, Gaynor, E R, Boldt, D H, Doroshow, J H, Bar, M H
Published in Journal of clinical oncology (01.02.1992)
Published in Journal of clinical oncology (01.02.1992)
Get more information
Journal Article
Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
Fisher, Richard I, Gaynor, Ellen R, Dahlberg, Steve, Oken, Martin M, Grogan, Thomas M, Mize, Evonne M, Glick, John H, Coltman, Charles A, Miller, Thomas P
Published in The New England journal of medicine (08.04.1993)
Published in The New England journal of medicine (08.04.1993)
Get full text
Journal Article
A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study
Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., Glick, J.H., Coltman, C.A., Miller, T.P.
Published in Annals of oncology (1994)
Published in Annals of oncology (1994)
Get full text
Journal Article
Conference Proceeding
Infusional CHOP Chemotherapy (CVAD) With or Without Chemosensitizers Offers No Advantage Over Standard CHOP Therapy in the Treatment of Lymphoma: A Southwest Oncology Group Study
GAYNOR, Ellen R, UNGER, Joseph M, MILLER, Thomas P, GROGAN, Thomas M, WHITE, Leonard A, MILLS, Glenn M, BALCERZAK, Stanley P, VARTERASIAN, Mary, LEBLANC, Michael, FISHER, Richard I
Published in Journal of clinical oncology (01.02.2001)
Published in Journal of clinical oncology (01.02.2001)
Get full text
Journal Article
The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells
Gaynor, E R, Vitek, L, Sticklin, L, Creekmore, S P, Ferraro, M E, Thomas, Jr, J X, Fisher, S G, Fisher, R I
Published in Annals of internal medicine (15.12.1988)
Published in Annals of internal medicine (15.12.1988)
Get more information
Journal Article
Daily Subcutaneous Ultra-Low-Dose Interleukin 2 with Daily Low-Dose Interferon-α in Patients with Advanced Renal Cell Carcinoma
CLARK, J. I, GAYNOR, E. R, MARTONE, B, BUDDS, S. C, MANJUNATH, R, FLANIGAN, R. C, WATERS, W. B, SOSMAN, J. A
Published in Clinical cancer research (01.09.1999)
Get full text
Published in Clinical cancer research (01.09.1999)
Journal Article
Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen
Parkinson, D R, Fisher, R I, Rayner, A A, Paietta, E, Margolin, K A, Weiss, G R, Mier, J W, Sznol, M, Gaynor, E R, Bar, M H
Published in Journal of clinical oncology (01.10.1990)
Published in Journal of clinical oncology (01.10.1990)
Get more information
Journal Article
A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma
Dutcher, J P, Gaynor, E R, Boldt, D H, Doroshow, J H, Bar, M H, Sznol, M, Mier, J, Sparano, J, Fisher, R I, Weiss, G
Published in Journal of clinical oncology (01.04.1991)
Published in Journal of clinical oncology (01.04.1991)
Get more information
Journal Article
Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinoma
Gaynor, E R, Weiss, G R, Margolin, K A, Aronson, F R, Sznol, M, Demchak, P, Grima, K M, Fisher, R I, Boldt, D H, Doroshow, J H
Published in JNCI : Journal of the National Cancer Institute (05.09.1990)
Published in JNCI : Journal of the National Cancer Institute (05.09.1990)
Get more information
Journal Article
Phase II studies of recombinant human interleukin-4 in advanced renal cancer and malignant melanoma
Margolin, K, Aronson, F R, Sznol, M, Atkins, M B, Gucalp, R, Fisher, R I, Sunderland, M, Doroshow, J H, Ernest, M L, Mier, J W
Published in Journal of immunotherapy with emphasis on tumor immunology (01.02.1994)
Published in Journal of immunotherapy with emphasis on tumor immunology (01.02.1994)
Get more information
Journal Article
Colosplenic fistula in a patient treated with interleukin-2 for malignant melanoma
Chun, E S, Demos, T C, Gaynor, E R
Published in Journal of computer assisted tomography (01.07.1997)
Published in Journal of computer assisted tomography (01.07.1997)
Get more information
Journal Article
Long-term survival of patients with localized diffuse histiocytic lymphoma
Vokes, E E, Ultmann, J E, Golomb, H M, Gaynor, E R, Ferguson, D J, Griem, M L, Oleske, D
Published in Journal of clinical oncology (01.10.1985)
Published in Journal of clinical oncology (01.10.1985)
Get more information
Journal Article
Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution
Gaynor, E R, Ultmann, J E, Golomb, H M, Sweet, D L
Published in Journal of clinical oncology (01.12.1985)
Published in Journal of clinical oncology (01.12.1985)
Get more information
Journal Article
Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumors
Sparano, J A, Fisher, R I, Weiss, G R, Margolin, K, Aronson, F R, Hawkins, M J, Atkins, M B, Dutcher, J P, Gaynor, E R, Boldt, D H
Published in Journal of immunotherapy with emphasis on tumor immunology (01.10.1994)
Published in Journal of immunotherapy with emphasis on tumor immunology (01.10.1994)
Get more information
Journal Article
Low‐dose cytosine arabinoside (Ara‐C) therapy in the myelodysplastic syndromes and acute leukemia
Winter, Jane N., Variakojis, Daina, Gaynor, Ellen R., Larson, Richard A., Miller, Kenneth B.
Published in Cancer (01.08.1985)
Published in Cancer (01.08.1985)
Get full text
Journal Article
Prognostic significance of the Ki-67 : associated proliferative antigen in aggressive non-Hodgkin's lymphomas : a prospective Southwest oncology group trial
MILLER, T. P, GROGAN, T. M, SCHNITZER, B, TUBBS, R. R, GAYNOR, E. R, FISHER, R. I, DAHLBERG, S, SPIER, C. M, BRAZIEL, R. M, BANKS, P. M, FOUCAR, K, KJELDSBERG, C. R, LEVY, N, NATHWANI, B. N
Published in Blood (15.03.1994)
Published in Blood (15.03.1994)
Get full text
Journal Article